Roy Buchanan
Stock Analyst at JMP Securities
(1.56)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ENTA Enanta Pharma | Maintains: Market Outperform | 24 25 | 6.48 | 285.8% | 15 | Aug 12, 2025 | |
DVAX Dynavax Technologies | Maintains: Market Outperform | 31 32 | 10.47 | 205.64% | 7 | Aug 8, 2025 | |
CDTX Cidara Therapeutics | Maintains: Market Outperform | 59 66 | 61.9 | 6.62% | 7 | Aug 8, 2025 | |
PYPD PolyPid | Maintains: Market Outperform | 16 14 | 3.19 | 338.87% | 2 | Jun 17, 2025 | |
CVAC CureVac | Reiterates: Market Outperform | 10 10 | 5.42 | 84.5% | 9 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 5 2 | 1.05 | 90.48% | 9 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 1.45 | 1141.38% | 3 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 7 4 | 1.85 | 116.22% | 3 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 23 14 | 0.84 | 1566.67% | 1 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 33 33 | 69.02 | -52.19% | 1 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 24 7 | 0.84 | 733.33% | 2 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 4 5 | 3.34 | 49.7% | 5 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 443 448 | 638.76 | -29.86% | 2 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 14 16 | 10.06 | 59.05% | 1 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 16, 2023 |